Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

• Sofie Lock Johansson,
• Helle Wulf-Johansson,
• Anders Schlosser,
• Ingrid L. Titlestad,
• Bruce Miller,
• Ruth Tal-Singer,
• Uffe Holmskov,
• Jørgen Vestbo,
• Grith Lykke Sørensen

Affiliations

Sofie Lock Johansson

Dept of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark

Helle Wulf-Johansson

Dept of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark

Anders Schlosser

Dept of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark

Ingrid L. Titlestad

Dept of Respiratory Medicine, Odense University Hospital, Odense, Denmark

Bruce Miller

GlaxoSmithKline R&D, Collegeville, PA, USA

Ruth Tal-Singer

GlaxoSmithKline R&D, Collegeville, PA, USA

Uffe Holmskov

Dept of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark

Jørgen Vestbo

Dept of Respiratory Medicine, Odense University Hospital, Odense, Denmark

Grith Lykke Sørensen

Dept of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark